Ascendis Pharma A/S
ASND
$190.91
-$5.07-2.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 580.21M | 559.80M | 579.30M | 697.65M | 277.18M |
| Total Receivables | 142.36M | 83.03M | 183.70M | 56.16M | 86.45M |
| Inventory | 356.29M | 316.77M | 306.05M | 296.04M | 269.15M |
| Prepaid Expenses | 40.29M | 36.39M | 29.27M | 36.18M | 39.37M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.12B | 995.99M | 1.10B | 1.09B | 672.15M |
|
|
|||||
| Total Current Assets | 1.12B | 995.99M | 1.10B | 1.09B | 672.15M |
| Net Property, Plant & Equipment | 109.86M | 99.92M | 102.20M | 108.77M | 111.48M |
| Long-term Investments | -- | -- | 3.62M | -- | -- |
| Goodwill | -- | -- | 3.62M | -- | -- |
| Total Other Intangibles | 4.45M | 4.23M | 551.80K | 4.58M | 4.49M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.18M | 2.87M | 2.40M | 2.46M | 2.34M |
| Total Assets | 1.28B | 1.15B | 1.22B | 1.22B | 812.49M |
|
|
|||||
| Total Accounts Payable | 110.06M | 91.19M | 99.80M | 83.95M | 106.64M |
| Total Accrued Expenses | 46.89M | 41.14M | 70.36M | 47.11M | 28.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 542.98M | 529.57M | 508.89M | 501.60M | 486.00M |
| Total Finance Division Other Current Liabilities | 398.13M | 295.20M | 260.87M | 302.49M | 287.38M |
| Total Other Current Liabilities | 398.13M | 295.20M | 260.87M | 302.49M | 287.38M |
| Total Current Liabilities | 1.10B | 957.10M | 939.91M | 935.15M | 908.32M |
|
|
|||||
| Total Current Liabilities | 1.10B | 957.10M | 939.91M | 935.15M | 908.32M |
| Long-Term Debt | 298.91M | 300.56M | 297.68M | 293.94M | 147.81M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 88.86M | 85.64M | 80.29M | 84.07M | 86.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.08M | 9.11M | 12.69M | 15.30M | 13.55M |
| Total Liabilities | 1.50B | 1.35B | 1.33B | 1.33B | 1.16B |
|
|
|||||
| Common Stock & APIC | 2.91B | 2.67B | 2.54B | 2.73B | 2.31B |
| Retained Earnings | -3.13B | -2.87B | -2.65B | -2.84B | -2.65B |
| Treasury Stock & Other | 268.90K | 1.76M | 1.73M | 931.30K | 729.70K |
| Total Common Equity | -220.28M | -205.15M | -109.44M | -108.54M | -344.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -220.28M | -205.15M | -109.44M | -108.54M | -344.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -220.28M | -205.15M | -109.44M | -108.54M | -344.08M |
|
|
|||||